cancer vaccines
The field has proved useful for work in areas like antigen processing and neoantigen discovery, but technical challenges continue to limit the scope of its impact.
The company is leveraging immunogenic peptides created by cancer cells as diagnostic and vaccine targets in both humans and dogs.
Immunotherapy Response Features Identified in Pancreatic Cancer Microenvironment
Researchers compared tumor microenvironment features in pancreatic ductal adenocarcinoma cases receiving an allogeneic vaccine with or without anti-PD-1 treatment.
Evaxion Biotech Adopts Personalis Immune Profiling Platform for Melanoma Immunotherapy Trial
The companies will use Personalis' ImmunoID Next technology to analyze patient response to a combination of Evaxion's EVX-01 with the immunotherapy Keytruda.
BostonGene Collaborates With Transgene, NEC Corporation on Trials of Bespoke Cancer Vaccine
The firm will conduct genomic and transcriptomic analysis to identify predictors of response to the personalized immunotherapy TG4050.